Previously, we reported that silencing TRAF3IP2 resulted in reduced tumor size which is linked to reduced malignant cell proliferation8, this can be very well associated with reduced ATP levels as a result of targeting TRAF3IP2. This evidence concerns the gene TRAF3IP2 and neoplasm.